2022, Number 3
<< Back Next >>
Odovtos-Int J Dent Sc 2022; 24 (3)
Use of Ionized Monocalcium Phosphate and Enameline Derivatives to Reduce Dentin Hypersensitivity After Periondontal Therapy
Martínez-Aguilar VM, Peniche-Palma DC, Carrillo-Ávila BA, Sauri-Esquivel EA, Aguilar-Pérez FJ, Herrera-Atoche JR
Language: English
References: 26
Page: 152-160
PDF size: 141.27 Kb.
ABSTRACT
This study aimed to evaluate the effectiveness of using an ionized monocalcium phosphate and enamelin derivatives (IMP+ED) based mouthwash for the treatment of dentin hypersensitivity (DH) after scaling and root planing (SRP). 47 patients who reported DH after SRP treatment were included in this prospective cohort study. The Schiff Cold Air Sensitivity Scale (SCASS) was applied to classify their degree of pain in mild, moderate or intense at two times: after SRP (T0), and after one month of using a IMP+ED-based mouthwash (T1). The McNemar-Bowker test was used to compare the correlated proportions between both times (p‹0.05). After the SRP therapy (T0), all the sample members reported pain distributed in the following manner: 12.8% were mild, 27.6% moderate, and 59.6% intense. At one month since treatment and with the use of the IMP+ED-based mouthwash (T1), the distribution of pain levels changed to 83% mild, 12.8% moderate, and 4.3% intense, this change was statistically significant (p‹0.001). IMP+ED-based mouthwash produces a positive effect in reducing painful responses caused by exposure of the dentin tubules to the oral environment after SRP therapy.
REFERENCES
Salazar D., Nakouzi J., Salazar P.D., Nakouzi M.J. Clinical Evaluation Fluoride Varnish in the Management of Dentin Hypersensitivity. Int J Odontostomat. 2017; 11 (1): 41-6.
Romero-Amaro I.M., Escalona L., Acevedo A.M. Teorías y factores etiológicos involucrados en la hipersensibilidad dentinaria. Acta Odontol Venez. 2009; 47 (1): 260-9.
Shiau H.J. Dentin hypersensitivity. J Evid Based Dent Pract. 2012;12 (3 Suppl): 220-8.
Collaert B., Fischer C. Dentine hypersensitivity: a review. Dent Traumatol. 1991; 7 (4): 145-52.
Humphreys S.M. Henry James’s revisions for “the ambassadors.” Notes Queries. 1954; 199: 397-9.
Rane P., Pujari S., Patel P., Gandhewar M., Madria K., Dhume S. Epidemiological Study to Evaluate the Prevalence of Dentine Hypersensitivity among Patients. J Int oral Heal. 2013; 5 (5): 15-9.
Nanjundasetty J.K., Ashrafulla M. Efficacy of desensitizing agents on postoperative sensitivity following an in-office vital tooth bleaching: A randomized controlled clinical trial. J Conserv Dent. 2016; 19 (3): 207-11.
Orchardson R., Gillam D.G. Managing dentin hypersensitivity. J Am Dent Assoc. 2006; 137 (7): 990-8.
Moreau J.L., Sun L., Chow L.C., Xu H.H.K. Mechanical and acid neutralizing properties and bacteria inhibition of amorphous calcium phosphate dental nanocomposite. J Biomed Mater Res Part B Appl Biomater. 2011; 98B (1): 80-8.
Sharda S., Prasad K.V.V., Shetty P.J., Nikhil K. Effectiveness of Desensitizing Dentifrice and Mouthwash on Dentin Hypersensitivity and Tooth Remineralization. Contemp Clin Dent. 2018; 9 (3): 415-20.
Yates R., West N., Addy M., Marlow I. The effects of a potassium citrate, cetylpyridinium chloride, sodium fluoride mouthrinse on dentine hypersensitivity, plaque and gingivitis. J Clin Periodontol. 1998; 25 (10): 813-20.
Hurtado P., Tobar-Tosse F., Osorio J., Orozco L., Moreno F. Amelogénesis imperfecta: revisión de la literatura. Rev Estomatol. 2015; 23 (1): 32-41.
Banfield N., Addy M. Dentine hypersensitivity: Development and evaluation of a model in situ to study tubule patency. J Clin Periodontol. 2004; 31 (5): 325-35.
Caton J.G., Armitage G., Berglundh T., Chapple I.L.C., Jepsen S., Kornman K.S., et al. A new classification scheme for periodontal and peri-implant diseases and conditions-Introduction and key changes from the 1999 classification. J Periodontol. 2018; 89 (S1): 1-8.
Schiff T., Dotson M., Cohen S., De Vizio W., McCool J., Volpe A. Efficacy of a dentifrice containing potassium nitrate, soluble pyrophosphate, PVM/MA copolymer, and sodium fluoride on al hypersensitivity: a twelve-week clinical study. Journal of Clinical Dentistry. 1994; 5: 87-92.
Faul F., Erdfelder E., Lang A.G., Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007; 39 (2): 175-91.
Pepelassi E., Rahiotis C., Peponi E., Kakaboura A., Vrotsos I. Effectiveness of an in-office arginine-calcium carbonate paste on dentine hypersensitivity in periodontitis patients: A double-blind, randomized controlled trial. J Clin Periodontol. 2015; 42 (1): 37-45.
Madhurkar J.G., Bhat P.R., Acharya A.B., Thakur S.L., Trasad V.A. Efficacy of milkas a desensitizing agent for the treatment of sensitivity following scaling and root planing. Contemp Clin Dent. 2017; 8 (2): 231-5.
Yales R., West N., Addy M., Marlow I. The effects of a potassium citrate, cetylpyridinium chloride, sodium fluoride mouthrinse on dentine hypersensitivity, plaque and gingivitis. A placebo-controlled study. J Clin Periodontol. 1998; 25 (10): 813-20.
Gillam D.G. Efficacy of a potassium nitrate mouthwash in alleviating cervical dentine sensitivity (CDS). J Clin Periodontol. 1996; 23 (11): 993-7.
Pereira R., Chava V.K. Efficacy of a 3% Potassium Nitrate Desensitizing Mouthwash in the Treatment of Dentinal Hypersensitivity. J Periodontol. 2001; 72 (12): 1720-5.
Hu D., Stewart B., Mello S., Arvanitidou L., Panagakos F., De Vizio W., et al. Efficacy of a mouthwash containing 0.8% arginine, PVM/MA copolymer, pyrophosphates, and 0.05% sodium fluoride compared to a negative control mouthwash on dentin hypersensitivity reduction. A randomized clinical trial. J Dent. 2013; 41 (Suppl. 1): 26-33.
Schiff T., Mateo L.R., Delgado E., Cummins D., Zhang Y.P., Devizio W. Clinical efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride compared to a dentifrice containing 8% strontium acetate and 1040 ppm fluoride under consumer usage conditions before. J Clin Dent. 2011; 22 (4): 128-38.
Iacob S., Veis A. Identification of the functional activity of the [A-4] amelogenin gene splice product in newborn mouse ameloblasts. Bone. 2008; 42 (6): 1072-9.
Papagerakis P., Ibarra J.M., Inozentseva N., DenBesten P., MacDougall M. Mouse amelogenin exons 8 and 9: Sequence analysis and protein distribution. J Dent Res. 2005; 84 (7): 613-7.
Fincham A.G., Hu Y., Lau E.C., Slavkin H.C., Snead M.L. Amelogenin post-secretory processing during biomineralization in the postnatal mouse molar tooth. Arch Oral Biol. 1991; 36 (4): 305-17.